Acceleron Pharma Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.76 |
Market Cap |
$2.2 B |
Shares Outstanding |
52.69 M |
Public Float |
43.08 M |
Address |
128 Sidney Street Cambridge Massachusetts 02139 United States |
Employees | - |
Website | http://www.acceleronpharma.com |
Updated | 07/08/2019 |
Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. |